BRISTOL MYERS SQUIBB CO — Investor Relations & Filings
Filings indexed
3,441
across all filing types
Latest filing
2026-01-05
Director's Dealing
Country
US
United States of America
Listing
US
BMY
Bristol Myers Squibb is a global biopharmaceutical company engaged in the discovery, development, licensing, manufacturing, and commercialization of innovative medicines. The company focuses on addressing serious diseases with significant unmet medical needs, with core therapeutic areas in oncology, immunology, and cardiovascular disease. Its operations encompass the entire product lifecycle, from scientific research and clinical trials to the global distribution and sale of its biopharmaceutical products. The company's mission is to help patients prevail over serious diseases through scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 Filing | 2026-01-05 | English | |
| 4 Filing | 2026-01-05 | English | |
| 4 Filing | 2026-01-05 | English | |
| 4 Filing | 2026-01-05 | English | |
| 4 Filing | 2026-01-05 | English | |
| CURRENT REPORT | 2025-11-18 | English |
Browse filings by year
33 years- 2026 35 filings
- 2025 112 filings
- 2024 108 filings
- 2023 116 filings
- 2022 126 filings
- 2021 152 filings
- 2020 190 filings
- 2019 221 filings
- 2018 114 filings
- 2017 115 filings
- 2016 144 filings
- 2015 149 filings
- 2014 139 filings
- 2013 169 filings
- 2012 163 filings
- 2011 139 filings
- 2010 146 filings
- 2009 170 filings
- 2008 132 filings
- 2007 131 filings
- 2006 176 filings
- 2005 162 filings
- 2004 151 filings
- 2003 67 filings
- 2002 20 filings
- 2001 20 filings
- 2000 12 filings
- 1999 8 filings
- 1998 9 filings
- 1997 10 filings
- 1996 15 filings
- 1995 11 filings
- 1994 9 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 15475087 | 4 Filing | 2026-01-05 | English | ||
| 15475055 | 4 Filing | 2026-01-05 | English | ||
| 15475041 | 4 Filing | 2026-01-05 | English | ||
| 15474977 | 4 Filing | 2026-01-05 | English | ||
| 15474967 | 4 Filing | 2026-01-05 | English | ||
|
2025
10 filings
| |||||
| 9019608 | CURRENT REPORT | 2025-11-18 | English | ||
| 9019610 | NYSE CERTIFICATION | 2025-11-12 | English | ||
| 9019612 | 8-A12B | 2025-11-10 | English | ||
| 8223347 | FORM 8-K | 2025-11-10 | English | ||
| 8223348 | 424B5 | 2025-11-07 | English | ||
| 8223349 | FWP | 2025-11-05 | English | ||
| 8223350 | FORM 4 | 2025-11-04 | English | ||
| 8223351 | FORM 4 | 2025-11-04 | English | ||
| 8223352 | FORM 4 | 2025-11-04 | English | ||
| 8223354 | FORM 4 | 2025-11-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BRISTOL MYERS SQUIBB CO via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29889/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29889 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29889 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29889 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29889}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BRISTOL MYERS SQUIBB CO (id: 29889)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.